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Summary
In a retrospective analysis of 35 Black patients with
chronic active hepatitis (CAH) admitted to Barag-
wanath Hospital, Johannesburg, during the period
1972-1980, four major aetiological categories were
found: auto-immune (lupoid, immunological (57%»,
drug-induced (isoniazid and a-methyldopa (17%»,
heptatitis B virus-related (14%), and alcohol-related
(11%) CAH. Alcohol-related CAH was found in
males only. Upper abdominal pafn was a presenting
feature of alcohol-induced CAH, while jaundice was
a common. presenting feature of the other types.
Systemic features such as skin rashes (acne, urtica-
ria), bacterial infections and congestive cardiac
failure were prominent in the auto-immune type of
CAH. The liver was enlarged in the majority of
cases. Hepatitis B virus-related CAH showed an
absence of tissue nonspecific auto-antibodies. Cir-
rhosis was present in approximately 50% of patients
at the time of diagnosis. Despite the facts that isoni-
azid and a-methyldopa are commonly used and
hepatitis B infections and alcohol abuse are 'fre-
quent in this population, CAH. remains an uncom-
mon condition in South African Blacks.
S Air Med J 1983: 63: 602,604.
Chronic active hepatitis (CAH) is a liver disease ofvaried aetiol-
ogy and variable clinical features. The diagnosis of CAH is
essentially pathological and 'the features common to all untreated
cases are piecemeal necrosis together with new fibre formation
and a lymphocytic infiltration ofthe portal tracts and lobules .
bridging or multilobular hepatocyte necrosis may be present .
cirrhosis may develop'. I CAH may be caused by viruses (hepati-
tis B virus and non-A, non-B hepatitis viruses), drugs
(a-methyldopa, isoniazid, oxyphenisatin, nitrofurantoin, sul-
phonamides, propylthiouracil, perhexilene maleate, dantrolene
sodium, aspirin, halothane), ethyl alcohol abuse, Wilson's
disease, ulcerative colitis, Crohn's disease, ai-antitrypsin defi-
ciency and auto-immune disorders (i.e. lupoid or immu-
nological).
During the period 1972-1980 35 Black patients with CAH
were seen at Baragwanath Hospital, Johannesburg. The aetio-
logy and the clinical, biochemical and immunological features of
the disease were analysed retrospectively.
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Patients and methods
Patients were only included in the analysis if they satisfied the
clinical, biochemical, immunological and, most impomlnt, the
histological criteria for CAH. In this regard, importan! points
included a history of recurrent jaundice, multisvstem disease,
e\'idence of chronic liver disease, a tenfold increa;e in the serum
aspartate aminotransferase (AST) level or a fivefold increase in
the AST level and a twofold increase in the serum gammaglo-
bulin level, the presence of nonspecific auto-antibodies such as
the lupus erythematosus (LE) cell phenomenon, antinuclear
factor (AN F), anti-smooth-muscle antibody (AS MA) and anti-
mitochondrial antibody (AMA), evidence of piecemeal necrosis,
portal tract infiltration, fibrosis, bridging or multilobular necro-
sis, cirrhosis and response to steroids. The different aetiological
groups are defined as follows: (i) auto-immune (lupoid, immuno-
logical) CAH - history, clinical examination, including multi-
systemic involvement and the absence of other aetiological fac-
tors; (il) post-hepatitis B and non-A, non-B hepatitis-related
CAH - history of blood transfusion(s), serological evidence of
hepatitis B virus infection; (iii) drug-induced CAH - history of
ingestion of a drug, absence of other aetiological factors and
regression of the disease following withdrawal of the initiating
agent; (iv) alcohol-induced CAH - history of alcohol abuse,
appropriate clinical features, including Dupuytren's contrac- .
ture, bilateral parotid enlargement, palmar erythema, spider
angiomas, gynaecomastia (in males) and histological features of
alcoholic liver disease (steatonecrosis, hepatitis with cell necro-
sis, polymorph infiltration, Mallory's hyalin and micronodular
cirrhosis; (v) CAH related to ulcerative colitis and Crohn's di-
sease - clinical and radiological evidence of chronic inflamma-
tory bowel disease; (VI) Wilson's disease - family history and
past history of chronic liver disease, haemolysis, central nervous
system disease, evidence of basal ganglia disease, presence of
Kayser-Fleischer rings, low serum ceruloplasmin and raised
urinary and hepatic copper levels; and (vii) a ,-antitrypsin
deficiency-related CAH - history of jaundice during infancy,
clinical features of emphysema and periodic acid-Schiff (PAS)-
positive globules in the hepatocytes.
A full blood count, measurement of the ESR (Westergren),
urea and electrolyte values and prothrombin index, liver func-
tion tests (serum bilirubin, AST, alanine aminotransferase, lactic
dehydrogenase, alkaline phosphatase, total protein, serum
albumin) and LE cell, A F, ASMA and AMA tests were per-
formed in all patients using standard methods. Hepatitis B sur-
face antigen was determined in the serum of patients by immu-
nodiffusion (8 patients), immuno-electrophoresis (10 patients)
and complement fixation (4 patients) - in 12 ofthese patients all
three methods were used - and by revl=r-~ed passive haemag-
glutination (13 patients). Percutaneous liver biopsy was per-
formed in all but 1 of the patients.
Results
Data were first analysed according to aetiology (Table I). Only
four types ofCAH were found: (i) auto-immune (lupoid, immu-
nological); (ii) hepatitis B virus-related CAH; (iiz) alcohol-
SA EOIESE T OS RIF OEEL 63 16 APRIL 1983 603









































































































related CAH; and (i'v) drug-induced CAH. The commone t type
wa auro-immune AH (20 patient ). Thi wa followed by
drug-induced CAH (6 patient ), the drug being i oniazid (5
patient) and a-methyldopa (I patient). The next commone t
type was hepatiti B viru -related CAH (5 patient ). Alcohol-
related CAH was found in only 4 patients, who had been inge t-
ing alcohol for period ranging from 2 month to 2 year (mean
7,5 month ). Alcohol-related CAH occur in an older age group
than do the other type of CAH, and predominantly in male ,
unlike auto-immune and drug-induced AH.
Pre enting features, symptoms and ign
Jaundice was a common pre enting feature in patient with
auto-immune, drug-induced and hepatiti B viru -related AH.
The presenting feature in all patient in the alcohol-related AH
group w upper abdominal pain. Epi taxis due to evere throm-
bocytopenia was the presenting feature in I patient with auto-
immune H. In the hepatiti B viru -related AH group 2
patient pr ented with hepatic encephalopathy while I w
admined with bilateral pyramidal tract ign.
ardiac failure was present in 3 patient with auto-immune
AH the cau e being evere aortic teno i (I patient), prob-
able rheumatic mitral regurgitation (I patient) and a mitral
ubvalvular left \'entricular aneury m (I patient). Fa ial acne (10
patient ) w a prominent feature in t he auto-immune and drug-
induced group, which al 0 shared other clini ai, bi hemi al
and immunological feature. A patient with auto-immune H
developed cutaneou v culiti, fibro ing ah'eoliti and arthriti .
Infection uch ab ces es (2 patient ) and ba erial pneumonia
(2 patient) were common in the auto-immune group.
Liver function
Overall liver function tests howed that the patient had
moderately active chronic liver di ea e. TI ue non peclfic auto-
antibodies were ab ent in the hepatiti B-relat d AH r up.
irrho i w pre ent in approximatel SOothe patient at
the time of diagn i.
au e of death
A total of 7 patient died. In patient wnh lupoid C H death
was caused by liver failure (1 patient), bacterial perit niti (I
patient), and intra-abdominal haemorrhage foll wmg percu-
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taneous liver biopsy performed under platelet cover in a patient
with thrombocytopenia (I patient). Hepatocellular carcinoma (I
patient) and botryomycosis (I patient) were the causes of death
in the alcohol-related CAH group. In the drug-induced CAH
group I patient died from variceal haemorrhage, and carcinoma
of the oesophagus was responsible for the death of I patient in the
hepatitis B virus-related CAH group.
Follow-up
A total of 24 patients were lost to follow-up and some were
followed up for a short period only. All but I patient in the
drug-induced CAH group responded to withdrawal of the
incriminating drug. Of the patients in whom long-term follow-
up was possible, 4 with auto-immune CAH were initially treated
with glucocorticoids and responded well to treatment. They are
now not receiving treatment because their disease is inactive and
they are well 5 years after diagnosis.
Discussion
In this retrospective study of CAH at Baragwanath Hospital
certain interesting features emerged. The common drugs impli-
cated in our series were isoniazid and a-methyldopa. Goldstein
e£ al. 2 found a drug aetiology in 67% of patients with histological
criteria of CAH, the drugs implicated being oxyphenisatin (9
patients) and methyldopa (5 patients). A variable period of drug
ingestion may produce CAH, the periods varying from 2 months
to as long as 3 years. Drug-induced CAH is an important entity
to recognize, since clinical improvement or lack ofprogress ofthe
liver disease occurs after withdrawal of the incriminating drug. If
no response to the withdrawal ofthe drug occurs, glucocorticoids
should be used. Clinically, biochemically, immuno-
logically and histologically, drug-induced CAH may be similar
to auto-immune CAH. 3 It is not clear whether the drugs precipi-
tate CAH in susceptible individuals.
In the UK and Australia the commonest type is the auto-
immune CAH, and females are most frequently affected. Our
studies show a fairly even sex distribution, as do the series
reported from Zimbabwe4 and Cape Town. 5 However, in the
former series auto-immune phenomena were absent. A propor-
tion of these were possibly hepatitis B-related. Of our patients
37% developed jaundice within a 3-month period.
Prednisolone alone or a small dose of prednisolone combined
with azathioprine are the drugs of choice for treatment onupoid
hepatitis. 6 Total (i.e. clinical, biochemical and histological) re-
mission can be expected in 56% of patients with severe disease
after a mean of21 months of treatment. 7
Prednisolone significantly improves survival, especially in the
first 5 years of therapy. 8 In these years death usually results from
hepatocellular failure, which becomes uncommon later. Spon-
taneous remission can also occur in 20% of patients with severe
disease, in which the natural history is progression to inactive
macronodular cirrhosis. 8
Hepatitis B virus-related disease is the commonest cause of
CAH in the Mediterranean littoral, the Middle East and Asia.
Hepatitis B virus-related CAH typically affects elderly males.
Auto-antibodies are typically absent, as in our series, and hyper-
globulinaemia is rare. The response to steroids is uncertain.
Several studies show that patients in this group respond poorly
to glucocorticoids. 9 Antiviral agents would be a rational form of
treatment.
At present no defmitive test is available for the detection of
hepatitis non-A, non-B viius(es), so that this group of CAH
cannot be completely excluded. Serum ceruloplasmin values in
our patients were normal. There was no clinical, radiological or
biochemical evidence of chronic inflammatory bowel disease or
ai-antitrypsin deficiency. These are all rare causes of CAH.
Many of the precipitating causes of CAH are commo~in our
Black population. Hepatitis B infections are common and the
carrier rate in urban Blacks is 4% (M. C. Kew, G. Macnab -
unpublished data). Tuberculosis is rife an·d isoniazid remains the
most commonly used drug. Hypertension occurs in up to 33% of
urban Blacks in the 4th decade,lo and a-methyldopa is fre-
quently used. Alcohol abuse is the commonest social problem
encountered.
An increasing awareness of the condition may result in its
being diagnosed more frequently, but despite the fact that risk
factors are common in urban Blacks, CAH remains a rare condi-
tion. A possible explanation for this anomaly is that the condition
is missed or that patients, who are largely asymptomatic, do not
attend for treatment. The natural history of the disease suggests
that many of these patients would eventually present with cryp-
togenic cirrhosis. This condition is, however, uncommon in our
experience at Baragwanath Hospital. An alternative explanation
is that this population is not susceptible to CAH, and further
studies are indicated.
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